AE105 is a small peptide that acts as a uPAR agonist, and together with ICG, constitutes a fluorescent probe that targets uPAR-expressing tumor cells and at the same time can be followed throughout the body with fluorescence imaging techniques. Here, PLAUR is linked to neoplasm.